Characterization of human CD39+ Th17 cells with suppressor activity and modulation in inflammatory bowel disease
about
Purinergic Signaling in Gut Inflammation: The Role of Connexins and PannexinsThe role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trialsProgesterone-Based Therapy Protects Against Influenza by Promoting Lung Repair and Recovery in FemalesIL-22, GM-CSF and IL-17 in peripheral CD4+ T cell subpopulations during multiple sclerosis relapses and remission. Impact of corticosteroid therapy.Human ectonucleotidase-expressing CD25(high) Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions.Adenosine influences myeloid cells to inhibit aeroallergen sensitization.Regulation of the T Cell Response by CD39.The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease.The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.Role of AHR and HIF-1α in Glioblastoma Metabolism.Th17 Responses to Collagen Type V, kα1-Tubulin, and Vimentin Are Present Early in Human Development and Persist Throughout Life.Purinergic signaling during intestinal inflammation.Bilirubin suppresses Th17 immunity in colitis by upregulating CD39.Dendritic cell targeted HIV-1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8+ T cells.The Hypoxia-Adenosine Link during Intestinal Inflammation.A commensal bacterial product elicits and modulates migratory capacity of CD39(+) CD4 T regulatory subsets in the suppression of neuroinflammation.Effects of HIV on metabolic and biological pathways of CD4+ T lymphocytes.Expression of Ecto-nucleoside Triphosphate Diphosphohydrolases-2 and -3 in the Enteric Nervous System Affects Inflammation in Experimental Colitis and Crohn's Disease.CD39 is upregulated during activation of mouse and human T cells and attenuates the immune response to Listeria monocytogenes.
P2860
Q26738433-39BF29F7-2447-4557-8F70-7F01EDCC0039Q27001546-B03FF81C-8E79-4D81-A2AA-0267B9A74229Q27468701-8B6A388C-A205-48F2-BA9C-8953E61CD915Q36310557-56D161EF-36A3-4A36-A87D-CB9ABAA75AB1Q36597320-8A64F8A6-404D-4A0A-9386-55FD27406000Q36976612-146B05B5-66CA-4C80-968E-B6DC769ABA33Q38847228-B3B184C4-898E-4336-A7FC-5C61A9ADE867Q38926183-A24D7637-C1AA-4B1C-AD0C-6C01C30ADB18Q39161005-D18853A5-3DFC-4008-AF7F-30EF5B48CF4BQ39187735-E3D10928-6C37-46FD-A4B1-E5C486837E38Q39228029-61CFF9AA-FE87-4F6C-8AB1-8E5AE0DFB425Q39331824-769E2199-E727-4069-BB8C-D7235BB17D43Q42289803-5D73ACE7-75E2-4CBD-8C1C-7EAE6E0D45AAQ45074789-1894C732-876E-4B55-97AA-6F5CCCF422D3Q48191363-1F06859C-C797-4478-ADB1-971286E22E52Q48669047-C48F6DD7-38A3-4C65-AE16-CDE77AF81E21Q49875304-B2DDE46A-74D1-439B-8677-B452B69E49CAQ52773017-3F7C2335-6646-4BD1-9A43-86D862DD3953Q54217234-71BE2BAA-E98F-4DD9-A573-FBF98070660C
P2860
Characterization of human CD39+ Th17 cells with suppressor activity and modulation in inflammatory bowel disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Characterization of human CD39 ...... in inflammatory bowel disease
@ast
Characterization of human CD39 ...... in inflammatory bowel disease
@en
type
label
Characterization of human CD39 ...... in inflammatory bowel disease
@ast
Characterization of human CD39 ...... in inflammatory bowel disease
@en
prefLabel
Characterization of human CD39 ...... in inflammatory bowel disease
@ast
Characterization of human CD39 ...... in inflammatory bowel disease
@en
P2093
P2860
P1433
P1476
Characterization of human CD39 ...... in inflammatory bowel disease
@en
P2093
Adam Cheifetz
Aiping Bai
Francisco J Quintana
Huang Huang
Maria Serena Longhi
Simon C Robson
P2860
P304
P356
10.1371/JOURNAL.PONE.0087956
P407
P577
2014-02-05T00:00:00Z